InvestorsHub Logo
Followers 87
Posts 6641
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Tuesday, 02/27/2024 2:03:45 PM

Tuesday, February 27, 2024 2:03:45 PM

Post# of 42746
Company of interest Sanofi, who appears to have long ago converted their common shares of Kalobios into preferred shares, today released a 6-K regarding several of their mabs and clinical trials. Also included was a press release concerning the appointment of three new Independent Directors. I wonder if the new Independent Directors are being appointed to gain Nasdaq compliance in the US, ahead of the spin-off of their healthcare division.

https://www.sec.gov/Archives/edgar/data/1121404/000119312524047460/d702412d6k.htm